ARTICLE
12 May 2023

Communications And Marketing Changes From The Medicare Final Rule (CMS-4201-F)

AC
Ankura Consulting Group LLC

Contributor

Ankura Consulting Group, LLC is an independent global expert services and advisory firm that delivers end-to-end solutions to help clients at critical inflection points related to conflict, crisis, performance, risk, strategy, and transformation. Ankura consists of more than 1,800 professionals and has served 3,000+ clients across 55 countries. Collaborative lateral thinking, hard-earned experience, and multidisciplinary capabilities drive results and Ankura is unrivalled in its ability to assist clients to Protect, Create, and Recover Value. For more information, please visit, ankura.com.
The Contract Year 2024 Medicare Final Rule[1] (CMS-4201-F), published on April 12, 2023, provides a number of revisions to Medicare Advantage (MA) and Medicare Part D requirements.
United States Food, Drugs, Healthcare, Life Sciences

The Contract Year 2024 Medicare Final Rule[1] (CMS-4201-F), published on April 12, 2023, provides a number of revisions to Medicare Advantage (MA) and Medicare Part D requirements. This article focuses on the updates within this Final Rule surrounding section I. MA and Part D Communications and Marketing (Subpart V of 42 CFR Parts 422 and 423). This section of the Final Rule speaks to the goal of protecting beneficiaries from marketing strategies that may be "misleading" or "confusing" when enrolling in MA and Part D plans.

Plans will need to update their documentation (e.g., policies and procedures, job aids) and processes to account for these changes and ensure that internal personnel and, if applicable, First Tier, Downstream or Related Entities (FDRs) (e.g., Third-Party Marketing Organizations (TPMOs)) comply with the revised requirements.

Plans have a quick turnaround to implement these regulations as they are effective on June 5, 2023, and the communications and marketing provisions will apply to the 2024 contract year (enrollment efforts for the 2024 contract year begin September 30, 2023). As marketing materials need to be produced, reviewed (internally by the plan sponsor), and approved by the Centers for Medicare and Medicaid Services (CMS) before they are distributed to prospective enrollees, these deadlines are actually much sooner (summer 2023).

Ankura has developed the following summary of the finalized proposals and suggestions for plans to consider when implementing these changes.

1314986a.jpg

1314986b.jpg

1314986c.jpg

1314986d.jpg

1314986e.jpg

1314986f.jpg

Ankura hopes that this summary has been helpful to you and your organization in preparing to implement these new requirements that were confirmed through the Final Rule. Ankura recommends that organizations review the documentation that has been published by the Department of Health and Human Services to understand the comments and responses to fully comprehend the intent and how these changes influence your communications and marketing efforts for the 2024 contract year.

Footnote

1. Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly.https://www.federalregister.gov/public-inspection/2023-07115/medicare-program-contract-year-2024-policy-and-technical-changes-to-the-medicare-advantage-program

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More